Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJH8P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,917
Award facts
- Contract value 100% obligated
- $17,916.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,916.96 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 14, 2026, for the supply of IMFINZI 500 mg/10 mL vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 5, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis and falls under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
IMFINZI (durvalumab) is an immunotherapy medication used primarily in oncology treatment, and this delivery order represents a task order against the existing pharmaceutical prime vendor contract framework. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills similar orders for prescription medications, specialty drugs, and medical commodities across multiple therapeutic domains through its DLA contract vehicle. The company's capability to compete successfully on a full and open basis demonstrates its established position as a reliable supplier of essential pharmaceutical products to military treatment facilities and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJH8P?
SPE2DR26FJH8P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH8P worth?
The government has obligated $17,917 on SPE2DR26FJH8P.
Is contract SPE2DR26FJH8P an order under another contract?
Yes. SPE2DR26FJH8P is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH8P competed?
The extent of competition for SPE2DR26FJH8P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award